Abstract: Provided is a wireless communication terminal that communicates wirelessly. The terminal includes: a transceiver; and a processor. The processor is configured to transmit first information on a fragmentation level to be used for data to be transmitted to a recipient by using the transceiver in an add Block ACK (ADDBA) setup procedure.

Abstract: Systems and methods for sequestering emissions from marine vessels are provided. Emissions (either flue gas from exhaust or CO2 carried on the ship under pressure in gas cylinders or CO2 obtained during the ships travel via capture) are mixed in a reactor with sea water (e.g., via gas exchange through head-space equilibration or bubbling through a diffuser) until a pH of 5.5 to 6.5 is obtained. Systems and reactors pump seawater through a reactor vessel containing a reaction medium (e.g., carbonates and silicates). The reactor produces an effluent that can be expelled into the ocean. The effluent produced from the result of a reaction according to embodiments has approximately twice the concentration of Dissolved Inorganic Carbon (DIC) and Alkalinity (Alk) as the incoming sea water and has an increased Ca+2 concentration above sea water.

Abstract: A communication device is configured to correlate a first signal with a second signal at a designated interval, the second signal corresponding to the first signal and being received by the communication device where the other communication device transmits a signal including a pulse as the first signal, convert a correlation computation result that is a result of correlating the first signal with the second signal at the designated interval into a format including a matrix product of an expanded modal matrix and an expanded signal vector, the expanded modal matrix including a plurality of elements indicating the correlation computation result obtained when assuming that the signals are received at respective set times, the expanded signal vector being a vector including a plurality of elements, each of which indicates whether or not there is a signal received at each of the set times and amplitude and phase of the signal.

Abstract: A method and system for preprocessing microscopic images. A method includes identifying a plurality of microglial cells shown in microglial cell channel images, wherein identifying the plurality of microglial cells further comprises quantizing the microglial cell channel microscopic images and filtering a plurality of objects in the quantized microglial cell channel microscopic images; identifying a soma and at least one projection for each of the plurality of microglial cells, wherein identifying the soma and the at least one projection for each microglial cell further includes iteratively removing pixels on the microglial cell as shown in one of the microglial cell channel images, wherein each soma and each projection has a respective size; and determining an activation state of each microglial cell based on the size of the soma and a total size of the at least one projection identified for the microglial cell.

Abstract: The invention relates to an electrically insulating composite material (1) comprising a polyepoxide matrix (2) of cycloaliphatic type or of diglycidyl ether type in a content of less than 40% by mass, from 20 to 75% by mass of one or several micrometric and/or mesometric filler(s) (3), and from 0.1 to 20% by mass of at least one ionic liquid (4), the masses being expressed relative to the total mass of the electrically insulating composite material (1). The invention also relates to a method for manufacturing such an electrically insulating composite material (1), as well as its use for an electrically insulating support (9) in a metal-enclosed substation (5).

Abstract: Systems and methods related to reconfigurable medical devices are described. In some embodiments, a reconfigurable medical device may include a central core and a plurality of arms. The arms may be rotatably coupled to the central core such that the plurality of arms may rotate outwards away from the central core to selectively reconfigure the reconfigurable device between a retracted configuration and an expanded configuration. In an initial state, the arms may be biased outwards away from the central core into the expanded configuration. When the reconfigurable device is exposed to a temperature greater than a threshold temperature, the arms may be biased towards the central core into the retracted configuration. In some embodiments, a reconfigurable medical device may include therapeutic compound-loaded needles coupled to distal portions of the arms.

Abstract: An okra polygalacturonic acid having a uric acid-lowering effect, a method for preparing the same, and use of the same are disclosed. The method includes: smashing an okra, lixiviating the okra in ethanol, and filtering to obtain a filtrate and a residue; removing the filtrate, and lixiviating the residue in heated water to obtain an extraction solution; adding the ethanol into the extraction solution to precipitate okra crude polysaccharides; purifying the okra crude polysaccharides over an anion exchange column by eluting with water or a NaCl solution, a Tris-HCl solution or a NaCl-containing Tris-HCl solution, or a phosphate solution or a NaCl-containing phosphate solution, and collecting a fraction eluted by the NaCl solution, the NaCl-containing Tris-HCl solution, or the NaCl-containing phosphate solution; and concentrating, dialyzing and drying the fraction to obtain the okra polygalacturonic acid.

Abstract: The present invention provides novel compounds of Formula (I), and pharmaceutically acceptable salts, solvates, hydrates, polymorphs, co-crystals, tautomers, stereoisomers, isotopically labeled derivatives, prodrugs, and compositions thereof. Also provided are methods and kits involving the inventive compounds or compositions for treating and/or preventing proliferative diseases (e.g., cancers (e.g., leukemia, acute lymphoblastic leukemia, lymphoma, Burkitt's lymphoma, melanoma, multiple myeloma, breast cancer, Ewing's sarcoma, osteosarcoma, brain cancer, neuroblastoma, lung cancer, colorectal cancer), benign neoplasms, diseases associated with angiogenesis, inflammatory diseases, autoinflammatory diseases, and autoimmune diseases) in a subject. Treatment of a subject with a proliferative disease using a compound or composition of the invention may inhibit the aberrant activity of a kinase, such as a cyclin-dependent kinase (CDK) (e.g.

Abstract: A deformable sensor comprises an enclosure comprising a deformable membrane, the enclosure configured to be filled with a medium, and an imaging sensor, disposed within the enclosure, having a field of view configured to be directed toward a bottom surface of the deformable membrane. The imaging sensor is configured to capture an image of the deformable membrane. The deformable sensor is configured to determine depth values for a plurality of points on the deformable membrane based on the image captured by the imaging sensor and a trained neural network.

Abstract: The present invention relates to therapeutic and prophylactic methods based on inhibition of CIS in NK cells. In particular, the present invention relates to treating or preventing a NK-responsive condition by administering to a subject a CIS inhibitor, or administering CIS-inhibited NK cells.

Abstract: The present invention relates to therapeutic and prophylactic methods based on inhibition of CIS in NK cells. In particular, the present invention relates to treating or preventing a NK-responsive condition by administering to a subject a CIS inhibitor, or administering CIS-inhibited NK cells.

Abstract: Embodiments of a recombinant human Parainfluenza Virus (hPIV) F ectodomain trimer stabilized in a prefusion conformation are provided. Also disclosed are nucleic acids encoding the hPIV F ectodomain trimer and methods of producing the hPIV F ectodomain trimer. Methods for inducing an immune response in a subject are also disclosed. In some embodiments, the method can be a method for treating or inhibiting a hPIV infection in a subject by administering a effective amount of the recombinant hPIV F ectodomain trimer to the subject.

Abstract: The present disclosure relates to compositions and methods for the diagnosis and treatment or prevention of proteinopathies, particularly MUC1-associated kidney disease (ADTKD-MUC1 or MKD), Retinitis Pigmentosa (e.g., due to rhodopsin mutations), autosomal dominant tubulo-interstitial kidney disease due to UMOD mutation(s) (ADTKD-UMOD), and other forms of toxic proteinopathies resulting from mutant protein accumulation in the ER or other secretory pathway compartments and/or vesicles, among others. The disclosure also identifies and provides TMED9-binding agents as capable of treating or preventing proteinopathies of the secretory pathway, and further provides methods for identifying additional TMED9-binding agents.

Abstract: An image encoding/decoding method is disclosed. An image decoding method of the present invention may comprise deriving an intra-prediction mode of a current block by using an intra-prediction mode of a neighbor block adjacent to the current block, configuring a reference sample of the current block, and performing intra-prediction on the current block by using the intra-prediction mode and the reference sample, wherein when the intra-prediction mode of the neighbor block is unavailable, the intra-prediction mode of the neighbor block may be replaced with a planar mode.

Abstract: A method and system provides the ability to detect density of a women's breast by obtaining the concentration of at least one selected biochemical in the breast using a spectrometer, and comparing the concentration obtained with reference measurements which correlate breast density with concentration of the at least one selected biochemical.

Abstract: Provided is a microorganism that is able to produce 2-phenylethanol at a high concentration, and a method of efficiently producing 2-phenylethanol by using a saccharide as a raw material. Provided is a coryneform bacterium transformant in which a shikimate pathway is activated, and further, a gene that encodes an enzyme having phenylpyruvate decarboxylase activity is introduced in such a manner that the gene can be expressed. Also provided is a 2-phenylethanol producing method that includes causing the coryneform bacterium transformant according to the present disclosure to react in water containing a saccharide.

Abstract: A method according to the present invention comprises the steps of: dividing SAR raw data into one or more sub-aperture data by a predetermined number in an azimuth direction; performing a spectral length extension FFT on the sub-aperture data in the azimuth direction; multiplying the sub-aperture data by a chirp scaling function; performing a range FFT on the sub-aperture data; performing range compression, SRC, and a bulk RCMC on the sub-aperture data; performing an inverse chirp-z transform on the sub-aperture data in a range direction; multiplying the divided sub-aperture data by a predetermined first function; performing an IFFT on the sub-aperture data in the azimuth direction; recombining the sub-aperture data; multiplying the recombined data by a second function and deramping same; performing an azimuth FFT on the recombined data; performing an azimuth IFFT on the recombined data; multiplying the recombined data by a third function and deramping same; performing the azimuth FFT on the recombined data;

Abstract: The present invention has been proposed to solve various problems including the above problems, and an object of the present invention is to provide a method of stabilizing carbon nanotubes by oxidizing catalyst metal particles included in the carbon nanotubes by oxidation heat treatment or by melting and removing the catalyst metal particles in a vacuum atmosphere. According to an aspect of the present invention to achieve the object, the method includes preparing carbon nanotubes including a catalyst metal and oxidizing the catalyst metal by heat-treating the carbon nanotubes. According to another aspect of the present invention to achieve the object, the method includes preparing carbon nanotubes including a catalyst metal, melting the catalyst metal by heat-treating the carbon nanotubes, and acid pickling the carbon nanotubes having undergone the melting process.

Abstract: The present invention relates to an apparatus for determining the location of a radiation source. The apparatus for determining the location of a radiation source according to the present invention comprises: a collimator part for selectively passing radiation therethrough according to the direction in which the radiation is incident; a scintillator part for converting the radiation incident from the collimator part into a light ray; a first optical sensor for converting the light ray incident from one end of the scintillator part into a first optical signal; a second optical sensor for converting the light ray incident from the other end of the scintillator part into a second optical signal; and a location information acquisition part for acquiring information on the location where the light ray is generated in the scintillator part, by using the second optical signal and the second optical signal.

Abstract: Provided is a production method of kakeromycin and a derivative thereof showing an antifungal activity and cytotoxicity and expected as a new antifungal agent or anticancer agent, by chemical synthesis. A production method of a compound represented by the formula (1): wherein R is an optionally substituted hydrocarbon group or an optionally substituted heterocyclic group; and n is 0 or 1, or a salt thereof, including a step of subjecting a compound represented by the formula (2): wherein R and n are as defined above, or a salt thereof, to an oxidation reaction.